These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9551757)

  • 1. Nicotine replacement: a new approach to reducing tobacco-related harm.
    Jiménez-Ruiz C; Kunze M; Fagerström KO
    Eur Respir J; 1998 Feb; 11(2):473-9. PubMed ID: 9551757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reduced smoking--a possible strategy for control of tobacco-associated illnesses?].
    Groman E; Kunze U; Schmeiser-Rieder A; Schoberberger R
    Versicherungsmedizin; 1999 Dec; 51(4):180-5. PubMed ID: 10630092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
    Le Houezec J; Säwe U
    J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Extreme solutions for those who do not succeed to quit smoking. About smokeless tobacco and harm reduction (part II)].
    Trofor A; Eşanu V; Frasilă EL
    Pneumologia; 2008; 57(3):178-81. PubMed ID: 18998333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health.
    Bates C; Fagerström K; Jarvis MJ; Kunze M; McNeill A; Ramström L
    Tob Control; 2003 Dec; 12(4):360-7. PubMed ID: 14660767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions to reduce harm from continued tobacco use.
    Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005231. PubMed ID: 17636791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extreme solutions for those who do not succeed to quit smoking. About smokeless tobacco and harm reduction].
    Trofor A; Eşanu V; Frăsilă EI
    Pneumologia; 2008; 57(2):105-8. PubMed ID: 18822878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobacco, nicotine and harm reduction.
    Le Houezec J; McNeill A; Britton J
    Drug Alcohol Rev; 2011 Mar; 30(2):119-23. PubMed ID: 21375611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smokeless tobacco as a nicotine delivery device: harm or harm reduction?
    Benowitz NL
    Clin Pharmacol Ther; 2011 Oct; 90(4):491-3. PubMed ID: 21934719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine.
    Mendoza-Baumgart MI; Tulunay OE; Hecht SS; Zhang Y; Murphy S; Le C; Jensen J; Hatsukami DK
    Nicotine Tob Res; 2007 Dec; 9(12):1309-23. PubMed ID: 18058349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Harm reduction strategy in tobacco control].
    Gorini G
    Epidemiol Prev; 2011; 35(3-4 Suppl 1):19-32. PubMed ID: 21926451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harm reduction policies for tobacco users.
    Gartner C; Hall W
    Int J Drug Policy; 2010 Mar; 21(2):129-30. PubMed ID: 19944582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing nicotine without smoke to save lives now: Evidence for harm minimization.
    Abrams DB; Glasser AM; Villanti AC; Pearson JL; Rose S; Niaura RS
    Prev Med; 2018 Dec; 117():88-97. PubMed ID: 29944902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No sisyphean task: how the FDA can regulate electronic cigarettes.
    Paradise J
    Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smokeless tobacco use: harm reduction or induction approach?
    Hatsukami DK; Lemmonds C; Tomar SL
    Prev Med; 2004 Mar; 38(3):309-17. PubMed ID: 14766113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
    Kozlowski LT
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the risks and benefits of nicotine replacement therapy for smoking cessation in the United States.
    Apelberg BJ; Onicescu G; Avila-Tang E; Samet JM
    Am J Public Health; 2010 Feb; 100(2):341-8. PubMed ID: 20019322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smokers making a quit attempt using e-cigarettes with or without nicotine or prescription nicotine replacement therapy: Impact on cardiovascular function (ISME-NRT) - a study protocol.
    Klonizakis M; Crank H; Gumber A; Brose LS
    BMC Public Health; 2017 Apr; 17(1):293. PubMed ID: 28376818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obsolete tobacco control themes can be hazardous to public health: the need for updating views on absolute product risks and harm reduction.
    Kozlowski LT; Abrams DB
    BMC Public Health; 2016 May; 16():432. PubMed ID: 27221096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An alternative approach to smoking control.
    Rodu B
    Am J Med Sci; 1994 Jul; 308(1):32-4. PubMed ID: 8010334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.